 |
|
|
| |
Impact of all-oral direct-acting antivirals on clinical and economic outcomes in chronic hepatitis C virus-infected patients in the U.S.
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Haesuk Park, Assistant Professor,
University of Florida College of Pharmacy
|
| |
|
|
|
|
|
